Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Gerrit Westera"'
Autor:
Simon M. Ametamey, Gerrit Westera, Pascale Gucker, Roland Schönbächler, Michael Honer, Jörg E. Spang, P. August Schubiger
Publikováno v:
CHIMIA, Vol 54, Iss 11 (2000)
A new cocaine derivative for imaging the dopamine transporter has been developed. Measurements of radioligand binding of 11C-(+)-McN-5652 in vivo with PET suggests that ecstasy interacts directly with the serotonin reuptake sites and that a single or
Externí odkaz:
https://doaj.org/article/0029adc6a705459990702b0b6d2efe9b
Autor:
Gerrit Westera, Bruno Weber, Matthias T. Wyss, Simon M. Ametamey, Achim H. Kaim, Beata Bode, Alfred Buck, Nicolas Späth, Michael Honer
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
For each oncological tracer it is important to know the uptake in non-tumorous lesions. The purpose of this study was to measure the accumulation of fluorine-18 choline (FCH), a promising agent for the evaluation of certain tumour types, in infectiou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754f955351157d0fcf17e1d066dbdcd5
http://doc.rero.ch/record/310147/files/259_2003_Article_1337.pdf
http://doc.rero.ch/record/310147/files/259_2003_Article_1337.pdf
Publikováno v:
Proceedings of 6th Eurasphalt & Eurobitume Congress.
Autor:
Boris B. Quednow, Gerrit Westera, Matthias T. Wyss, Alfred Buck, Nadja Dörig, Cyrill Burger, Felix Hasler, Franz X. Vollenweider, Katharina Rentsch, Valerie Treyer, Pius A. Schubiger
Publikováno v:
NeuroImage
Although alterations of serotonin (5-HT) system functioning have been proposed for a variety of psychiatric disorders, a direct method quantitatively assessing 5-HT release capacity in the living human brain is still lacking. Therefore, we evaluated
Autor:
Renata Mikolajczak, Sergio Todde, Gerrit Westera, Clemens Decristoforo, Philip H. Elsinga, Alain Faivre-Chauvet, G.-J. Meyer, Brit Farstad, Tanja Gmeiner-Stopar, Iván Peñuelas
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 37(5), 1049-1062. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging
This guidance is meant as a guidance to Part B of the EANM "Guidelines on Good Radiopharmacy Practice (GRPP)" issued by the Radiopharmacy Committee of the EANM (see www.eanm.org), covering the small-scale "in house" preparation of radiopharmaceutical
Autor:
Gerrit Westera, Christine Maier
Publikováno v:
Pharmazie in unserer Zeit. 34:506-513
Im Gegensatz zu den nicht radioaktiven Praparaten, welche vom Hersteller ausfuhrlich gepruft werden konnen, bewirkt der radioaktive Zerfall manchmal eine sehr enge Zeitspanne, in welcher die Radiopharmaka kontrolliert werden konnen. Aus produktionste
Publikováno v:
Journal of Medicinal Chemistry. 48:5123-5130
The homology models of the extracellular domains of the neuronal alpha4beta2 (pdb code: 1ole) and ganglionic alpha3beta4 (pdb code: 1olf) rat nicotinic acetylcholine receptor (nAChR) subtypes were refined and energetically minimized. In this work, a
Autor:
Hubert John, Thomas F. Hany, Gerrit Westera, Tibor Cservenyak, Daniel T. Schmid, Roland Zweifel, Gerhard W. Goerres, Gustav K. von Schulthess
Publikováno v:
Radiology. 235:623-628
Institutional review board approval and written informed consent were obtained. Patients with newly diagnosed prostate cancer and patients suspected of having recurrent prostate cancer were prospectively evaluated with fluorine 18 fluorocholine (FCH)
Autor:
Jörg T Patt, Gerrit Westera, Sonia Bertrand, Logos Curtis, Daniel Bertrand, Florence Chiodini, Jörg E Spang
Publikováno v:
European Journal of Pharmacology. 393:155-163
Interest in the field of nicotinic receptors has been recently stimulated both by the discovery of the potential therapeutic effects of new agonists, and by the discovery of an association between nicotinic receptor mutations and human neurological d
Autor:
Gerrit Westera, Daniel Bertrand, Jörg T Patt, Jörg E Spang, P. August Schubiger, Sonia Bertrand
Publikováno v:
FEBS Letters. 450:273-279
The frog toxin epibatidine is one of the most powerful ligands of the neuronal nicotinic receptors and derivatives show promising possibilities for labeling in positron emission tomography studies. In an attempt to reduce epibatidine toxicity, new me